Home
HelpTest Code DMDZ DMD Gene, Full Gene Analysis, Varies
Ordering Guidance
Targeted testing for familial variants (also called site-specific or known mutations testing) is available for variants identified in the DMD gene. See FMTT / Familial Variant, Targeted Testing, Varies. To obtain more information about this testing option, call 800-533-1710.
Testing for the DMD gene as a customized panel is available. For more information see CGPH / Custom Gene Panel, Hereditary, Next-Generation Sequencing, Varies.
Shipping Instructions
Specimen preferred to arrive within 96 hours of collection.
Specimen Required
Patient Preparation: A previous bone marrow transplant from an allogenic donor will interfere with testing. For instructions for testing patients who have received a bone marrow transplant, call 800-533-1710.
Specimen Type: Whole blood
Container/Tube: Lavender top (EDTA) or yellow top (ACD)
Acceptable: Any anticoagulant
Specimen Volume: 3 mL
Collection Instructions:
1. Invert several times to mix blood.
2. Send whole blood specimen in original tube. Do not aliquot.
Specimen Stability Information: Ambient (preferred)/Refrigerated
Additional Information: To ensure minimum volume and concentration of DNA is met, the preferred volume of blood must be submitted. Testing may be canceled if DNA requirements are inadequate.
Forms
1. New York Clients-Informed consent is required.
Document on the request form or electronic order that a copy is on file.
The following documents are available:
-Informed Consent for Genetic Testing (T576)
-Informed Consent for Genetic Testing (Spanish) (T826)
2. Molecular Genetics: Neurology Patient Information
3. If not ordering electronically, complete, print, and send a Neurology Specialty Testing Client Test Request (T732) with the specimen.
Useful For
Establishing a molecular diagnosis for patients with Duchenne muscular dystrophy and Becker muscular dystrophy
Identifying variants within DMD known to be associated with Duchenne muscular dystrophy or Becker muscular dystrophy, allowing for predictive testing of at-risk family members
Special Instructions
Method Name
Sequence Capture and Targeted Next-Generation Sequencing followed by Polymerase Chain Reaction (PCR) and Sanger Sequencing
Reporting Name
DMD Gene, Full Gene AnalysisSpecimen Type
VariesSpecimen Minimum Volume
1 mL
Specimen Stability Information
| Specimen Type | Temperature | Time | Special Container |
|---|---|---|---|
| Varies | Varies | ||
Reject Due To
All specimens will be evaluated at Mayo Clinic Laboratories for test suitability.Reference Values
An interpretive report will be provided.
Day(s) Performed
Varies
Report Available
21 to 35 daysPerforming Laboratory
Mayo Clinic Laboratories in Rochester
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
81408
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| DMDZ | DMD Gene, Full Gene Analysis | 22075-6 |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| 617533 | Test Description | 62364-5 |
| 617534 | Specimen | 31208-2 |
| 617535 | Source | 31208-2 |
| 617536 | Result Summary | 50397-9 |
| 617537 | Result | 82939-0 |
| 617538 | Interpretation | 69047-9 |
| 618177 | Additional Results | 82939-0 |
| 617539 | Resources | 99622-3 |
| 617540 | Additional Information | 48767-8 |
| 617541 | Method | 85069-3 |
| 617542 | Genes Analyzed | 48018-6 |
| 617543 | Disclaimer | 62364-5 |
| 617544 | Released By | 18771-6 |
NY State Approved
YesTesting Algorithm
For more information see Neuromuscular Myopathy Testing Algorithm